榴莲视频

Meeting Coverage >

AASLD

Lower is Better for PBC Candidate Drug

Safety signal for seladelpar disappeared at lower doses

Vets with HCV Might Settle Cancer Controversy

VA experience seems to rule out possible cancer-causing effect of new drugs

'Split Livers:' Life-Saving Options for Kids Who Need Transplant?

Divided-organ approach works in U.K., but may be a tough sell in U.S.

PBC Drug Shows Benefit Beyond Standard Response

Findings imply that ursodeoxycholic acid therapy should not be discontinued

EMR Alerts Up HCV Screening in Baby Boomers

But testing for hepatitis C virus still falls short of USPSTF guidelines

Novel Tx for Hepatic Encephalopathy Works Fast

Lowers ammonia level more quickly than standard care, study finds

Liver Ca Transplant Rates Vary by Ethnicity

Blacks have lower rates despite same degree of illness, study finds

AASLD Liver Meeting Covers a Lot of Ground

New science could 'potentially change the field'

PSC in Kids: Rare but Relentless

Large international cohort offers new insight

Timing of Meals Linked to Fatty Liver

Distributing calories during the day could reduce NAFLD risk

Marked Sex Difference Seen in Drug-Induced Liver Failure

Brain damage, polypharmacy more common in women with ALF

Investigative Combo Pill Effective Against HCV Infection

Treating refractory HCV without ribavirin onboard.

No Need for Cancer Watch in Cirrhotic Wilson's Disease

Hepatocellular carcinoma is too infrequent to merit regular surveillance.

Studies 'Validate' CDC HCV Testing Advice

WASINGTON -- Thousands of people in the U.S. -- including an estimated 50,000 veterans -- are infected with the hepatitis C virus, and don't know it, researchers reported here.

Supplements Blamed for Liver Toxicity

WASHINGTON -- The rate of liver damage caused by dietary and herbal supplements -- especially those used for bodybuilding -- appears to be on the rise, a researcher said here.

Babies Do OK if Mom on Tenofovir for Hepatitis B

WASHINGTON -- Pregnant women being treated for hepatitis B virus infections with the nucleotide inhibitor tenofovir (Viread) appeared to avoid transmission of the pathogen to their unborn children, researchers reported here.